1. Home
  2. SRDX vs DHIL Comparison

SRDX vs DHIL Comparison

Compare SRDX & DHIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • DHIL
  • Stock Information
  • Founded
  • SRDX 1979
  • DHIL 1990
  • Country
  • SRDX United States
  • DHIL United States
  • Employees
  • SRDX N/A
  • DHIL N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • DHIL Investment Managers
  • Sector
  • SRDX Health Care
  • DHIL Finance
  • Exchange
  • SRDX Nasdaq
  • DHIL Nasdaq
  • Market Cap
  • SRDX 415.4M
  • DHIL 392.1M
  • IPO Year
  • SRDX 1998
  • DHIL 1995
  • Fundamental
  • Price
  • SRDX $34.15
  • DHIL $148.97
  • Analyst Decision
  • SRDX Buy
  • DHIL
  • Analyst Count
  • SRDX 3
  • DHIL 0
  • Target Price
  • SRDX $43.00
  • DHIL N/A
  • AVG Volume (30 Days)
  • SRDX 342.3K
  • DHIL 26.3K
  • Earning Date
  • SRDX 08-08-2025
  • DHIL 07-29-2025
  • Dividend Yield
  • SRDX N/A
  • DHIL 4.05%
  • EPS Growth
  • SRDX N/A
  • DHIL 21.42
  • EPS
  • SRDX N/A
  • DHIL 17.58
  • Revenue
  • SRDX $120,801,000.00
  • DHIL $151,281,009.00
  • Revenue This Year
  • SRDX N/A
  • DHIL N/A
  • Revenue Next Year
  • SRDX $3.38
  • DHIL N/A
  • P/E Ratio
  • SRDX N/A
  • DHIL $8.47
  • Revenue Growth
  • SRDX N/A
  • DHIL 6.29
  • 52 Week Low
  • SRDX $26.00
  • DHIL $122.32
  • 52 Week High
  • SRDX $40.39
  • DHIL $173.25
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 43.47
  • DHIL 57.02
  • Support Level
  • SRDX $34.99
  • DHIL $147.24
  • Resistance Level
  • SRDX $37.77
  • DHIL $149.27
  • Average True Range (ATR)
  • SRDX 1.54
  • DHIL 2.41
  • MACD
  • SRDX -0.54
  • DHIL 0.84
  • Stochastic Oscillator
  • SRDX 3.28
  • DHIL 93.80

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About DHIL Diamond Hill Investment Group Inc.

Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.

Share on Social Networks: